Rousselot Biomedical in the media The potential of gelatin to optimize cell line development workflows European Biopharmaceutical Review October 2022, pages 68-70. © Samedan Ltd. Optimal gelatin-base biomaterial Medical Device development, 2022, Vol 1 Biomaterials: Challenges, Characteristics, and C

Nurturing hair beauty from the root with ingestible collagen peptides In the beauty market, there is currently a high demand for nutricosmetic products offering skin and hair beauty benefits. In the hair beauty segment, beyond the classic personal care products, consumers are increasingly relying on

Quali-Pure What is Quali-Pure? The Quali-Pure ® range of clinical grade gelatins offers medical manufacturers endotoxin-controlled gelatins, providing guaranteed biocompatibility, biodegradability, and batch-to-batch consistency. It is designed to meet high quality and safety standards. The whole ra

Ir. Tanja Vervust Global Director, Rousselot Biomedical Tanja holds an MSc in Bioscience Engineering from Ghent University and has over 25 years of experience with Rousselot. In January 2018, Tanja was appointed Global Director Rousselot Biomedical. Which aspect of your work inspires you the most? A

News overview Biomedical , rousselot Darling Ingredients’ Health Brand Rousselot Announces Online Access to Research- and Technical-Grade X-Pure Gelatins through BIO INX Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its hi

Science, research & development Rigorous science: the key to optimization, innovation and reliability In our aim to help you innovate and succeed in your market, we are constantly improving the performance of our ingredients. We seek to diversify our range of end products, reach new markets and unlo

Dr. Elien Gevaert Global R&D Manager Elien has a PhD in the field of liver tissue engineering and has spent several years working as a Post-Doctoral Researcher, publishing over 30 scientific papers in leading journals. Elien joined Rousselot in 2020 as a principal scientist where she leads on R&D. W

Blog overview Biomedical New possibilities in 3D bioprinting Making edits after printing is extremely difficult. Imagine if an author had to edit a novel after it was out in hardback, or if a journalist had to edit a newspaper that had been sent to print. Mar 25 Biomedical Transforming drug testing

Rapid, top-quality response to all inquiries Our Technical Support team is equipped and eager to help you get the best out of our products – and to make the most of your business. Product performance improvement: optimize your operation by selecting the best collagen peptide / gelatin for your produ

Whitepaper on Rousselot low endotoxin gelatins and collagens for biomedical applications. X-Pure Whitepaper: Low endotoxin gelatins and collagens for (bio)medical applications English X-Pure Whitepaper: Gelatin for safe micro- and submicron Particle applications English X-Pure Whitepaper: Low endoto